Fierce Pharma

SEPTEMBER 18, 2024

With its latest acquisition, women’s health outfit Organon is bringing its dermatology business to the U.S. with a potential blockbuster in tow. | Organon is set to acquire Roivant’s immuno-dermatology subsidiary Dermavant for up to $1.2 billion, the companies announced Wednesday. The crown jewel of the deal is undoubtedly Vtama, Dermavant’s steroid-free cream for plaque psoriasis, which is looking at a major expansion opportunity in eczema.

322

322

MedCity News

SEPTEMBER 18, 2024

The current model of siloed, proprietary development is failing us. It’s slow, expensive, and often results in technologies that never see the light of day. What if, instead, we embraced an open-source approach to medical device innovation? The post The FDA Isn’t Blocking Medical Breakthroughs — Our Outdated Innovation Model Is appeared first on MedCity News.

Medical 123

Medical FDA 123

Fierce Pharma

SEPTEMBER 18, 2024

This summer, GSK cut its yearly vaccine sales projection o | In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses compared with separate administration of the vaccines.

Sales 292

Sales 292

MedCity News

SEPTEMBER 18, 2024

By acquiring Dermavant, Organon gets Vtama, a drug approved for treating plaque psoriasis. An FDA decision for the topical cream in atopic dermatitis is expected by the end of 2024. The post Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary appeared first on MedCity News.

FDA 121

FDA Biopharma Pharma 121

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

SEPTEMBER 18, 2024

Since GSK’s Nucala and AstraZeneca’s Fasenra were approved two years apart to treat patients with severe asthma, the IL-5 inhibitors have engaged in a spirited market battle, with one key differenc | Locked in a spirited market battle with GSK's Nucala, AstraZeneca's Fasenra is catching up with its IL-5 inhibitor rival as the FDA signed off on its use to treat the rare autoimmune condition of eosinophilic granulomatosis with polyangiitis.

FDA 286

FDA Marketing Patients 286

MedCity News

SEPTEMBER 18, 2024

While fibrates are proven to lower triglyceride levels, which can serve as a biomarker for cardiovascular disease risk, several major clinical studies from the past 20 years have failed to show a benefit of fenofibrates over and above statins in further reducing heart-related events. The post Millions are Taking a Drug that Falls Short of its Promise to Lower Risk of Heart Attack appeared first on MedCity News.

FDA 113

FDA Physicians Biopharma Pharma 113

MedCity News

SEPTEMBER 18, 2024

In recent years, providers have been increasingly conducting tech pilots to see which solutions can best improve their clinical and operation success. During a panel at MedCity News’ INVEST Digital Health conference in Dallas, healthcare leaders shared their insight on how startups can best serve their provider partners during these pilots. The post 4 Things Startups Must Know to Achieve a Successful Tech Pilot appeared first on MedCity News.

Healthcare 110

Healthcare Healthcare Medical 110

Fierce Pharma

SEPTEMBER 18, 2024

Authors: | Unlock the potential of patient support data with effective information governance. Manage risks, ensure compliance, and drive innovation for better patient outcomes.

Government 130

Government Patients Management 130

pharmaphorum

SEPTEMBER 18, 2024

PBM Express Scripts has sued the FTC, claiming its recent report on the sector's role in drug pricing is defamatory and should be retracted

118

118

Integrity Solutions

SEPTEMBER 18, 2024

Banking sales strategies are being redefined: Here’s how to pivot your customer relationships. While every industry grapples with the volatility of the economic environment and market conditions, banking and financial services organizations are dealing with specific challenges emerging from multiple disruptive forces: These challenges include: Maintaining an acceptable margin in a volatile yield curve market.

Sales Strategy 84

Sales Strategy Sales Relationship management Consulting 84

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

SEPTEMBER 18, 2024

Novartis' Kisqali has claimed a broad FDA approval in early breast cancer that could give it an edge over rival Verzenio from Eli Lilly

FDA 101

FDA 101

Pharmaceutical Technology

SEPTEMBER 18, 2024

Kisqali generated $2bn in sales last year, with broader approvals forecasting sales of over $8bn by 2030, per GlobalData analysis.

Sales 98

Sales Patients FDA 98

MedCity News

SEPTEMBER 18, 2024

During a panel at the MedCity News INVEST Digital Health conference, three healthcare execs shared advice to startups on how to pitch to employers. They need to know their worth, understand the problem they’re solving, and think about issues globally. The post How Should Healthcare Startups Approach Employers? 3 Execs Weigh In appeared first on MedCity News.

Healthcare 69

Healthcare Healthcare 69

Pharmaceutical Technology

SEPTEMBER 18, 2024

Japan's MHLW has accepted for review GSK's NDA for Blenrep for patients with relapsed or refractory multiple myeloma.

Patients 98

Patients 98

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PharmaTimes

SEPTEMBER 18, 2024

It is hoped that the tool will improve the diagnostic pathway and free up radiologists’ time

Medical 99

Medical 99

PharmaVoice

SEPTEMBER 18, 2024

Overpromising, overcommitting and neglecting CMC are a few of the pitfalls that cause sponsors to stumble when submitting a new drug application.

76

76

pharmaphorum

SEPTEMBER 18, 2024

Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US.The bold move has been accompanied by a full-page ad in the Wall Street Journal explaining its reasoning, and claiming that the prices of GLP-1 drugs for weight loss are five times too high and need to be brought in line with levels in other countries.

59

59

Pharmaceutical Technology

SEPTEMBER 18, 2024

At the Clinical Trial Supply West Coast 2024 conference, serial biotech entrepreneur Umar Hayat said science should be allowed to advance without political interference.

Healthcare 59

Healthcare Healthcare 59

Advertisement

Evolve Your Success

SEPTEMBER 18, 2024

Unlock the secrets to excelling in medical sales! This episode promises to inspire and educate as we welcome Jon Alwinson, a veteran in the endoscopy sector, to share his remarkable career journey. Delve into Jon’s personal story, from the influence of his author father to his own four-year endeavor of writing a book aimed at guiding future medical sales reps.

Sales 52

Sales Medical sales Medical sales reps Medical 52

PharmaTech

SEPTEMBER 18, 2024

The drug manufacturing ecosystem Pharma 4.0, a term coined in 2017 by the International Society for Pharmaceutical Engineers, promises a revolution across drug discovery, manufacturing, and supply chain logistics, ensuring drugs are delivered precisely when needed, and improving overall patient care.

Manufacturing 52

Manufacturing Pharma Engineering Pharmaceutical 52

PM360

SEPTEMBER 18, 2024

Conshohocken, Pa., September 18, 2024 – Deerfield Group, one of the fastest-growing independent marketing and communications partners for healthcare and life science brands and companies, today announced two additions to its executive leadership team: Guy Varady will serve as Executive Vice President, Integrated Marketing, and Bob Josefsberg as Executive Vice President, Communications.

Marketing 52

Marketing Media Healthcare Healthcare 52

PharmExec

SEPTEMBER 18, 2024

Approval was based on data from the IND.227/KEYNOTE-483 trial, which demonstrated a 21% reduction in the risk of death when Keytruda was added to chemotherapy in patients with unresectable advanced or metastatic malignant pleural mesothelioma.

FDA 52

FDA Patients 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Commerce

SEPTEMBER 18, 2024

Accord BioPharma's 420 mg strength Hercessi (trastuzumab-strf), a biosimilar to Herceptin, gains FDA approval to treat HER2-overexpressing breast cancer and gastric cancer.

FDA 52

FDA Biopharma 52

PharmExec

SEPTEMBER 18, 2024

Approval was based on results from the MANDARA Phase III trial, which demonstrated the superiority of Fansenra over Nucala in patients with eosinophilic granulomatosis with polyangiitis.

FDA 52

FDA Patients 52

PharmaTimes

SEPTEMBER 18, 2024

The conference will return to Vienna AirportCity on 23 to 24 October 2024

81

81

PharmExec

SEPTEMBER 18, 2024

Ten-year data from the Phase III KEYNOTE-006 trial found that Keytruda produced a 34% ten-year overall survival rate compared to 23.6% for ipilimumab in patients with advanced melanoma.

Patients 52

Patients 52

Advertisement

Distribution

PharmaVoice

SEPTEMBER 18, 2024

The FDA’s backlog of overseas drug manufacturer inspections is still mounting — and new drugs could be delayed as a result.

FDA 59

FDA Manufacturing 59

PharmExec

SEPTEMBER 18, 2024

Results from the Phase II PHAROS trial found that treatment-naïve patients with BRAF V600E-mutant metastatic non-small cell lung cancer administered Braftovi in combination with Mektovi achieved an objective response rate of 75%.

Patients 52

Patients 52

Pharmacy Times

SEPTEMBER 18, 2024

The Drug Supply Chain Security Act (DSCSA) will soon mandate end-to-end tracking of pharmaceuticals throughout the supply chain, with numerous benefits for health systems.

Patients 57

Patients Pharmaceutical 57

PharmExec

SEPTEMBER 18, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52

Pharma 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales